Quick Answer
ADMA BIOLOGICS, INC. reported Total Assets of $624.24 million for fiscal year 2025.
ADMA BIOLOGICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $624.24M | +27.7% |
| 2024 | $488.68M | +48.5% |
| 2023 | $329.18M | -5.5% |
| 2022 | $348.46M | +26.1% |
| 2021 | $276.25M | +33.0% |
| 2020 | $207.67M | +63.4% |
| 2019 | $127.09M | +43.0% |
| 2018 | $88.88M | -17.7% |
| 2017 | $108.02M | +356.1% |
| 2016 | $23.69M | -0.1% |
| 2015 | $23.71M | -12.2% |
| 2014 | $27.02M | -15.5% |
| 2013 | $31.98M | +105.6% |
| 2012 | $15.56M | +431.6% |
| 2011 | $2.93M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $568.69M | +45.6% | +1.8% |
| June 30, 2025 | $558.38M | +48.3% | +9.4% |
| March 31, 2025 | $510.57M | +45.5% | +4.5% |
| December 31, 2024 | $488.68M | +48.5% | +25.1% |
| September 30, 2024 | $390.62M | +11.9% | +3.8% |
| June 30, 2024 | $376.40M | +9.7% | +7.3% |
| March 31, 2024 | $350.88M | +3.0% | +6.6% |
| December 31, 2023 | $329.18M | -5.5% | -5.7% |
- ADMA BIOLOGICS, INC. showed an increase of +27.7% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ADMA BIOLOGICS, INC.’s total assets has grown by 21235.0% (from $2.93 million to $624.24 million).
- The most recent figure is from ADMA BIOLOGICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: